Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes

Post-transplant lymphoproliferative disease (PTLD) represents a serious complication following allogeneic hematopoietic stem cell transplantation (alloHSCT). Previously, survival rates of PTLD have improved due to the introduction of rituximab. However, reports on curative management of refractory P...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Med (Lausanne)
Hauptverfasser: Mika, Thomas, Strate, Katharina, Ladigan, Swetlana, Aigner, Clemens, Schlegel, Uwe, Tischoff, Iris, Tischer-Zimmermann, Sabine, Eiz-Vesper, Britta, Maecker-Kolhoff, Britta, Schroers, Roland
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2019
Schlagworte:
Medicine
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6930172/
https://ncbi.nlm.nih.gov/pubmed/31921871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2019.00295
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge